SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-12-078249
Filing Date
2012-02-24
Accepted
2012-02-24 16:34:58
Documents
2
Group Members
INVUS ADVISORS, L.L.C.INVUS C.V.INVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.RAYMOND DEBBANEULYS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/AMENDMENT NO. 9 d303134dsc13da.htm SC 13D/A 28440
2 SUPPLEMENT NO. 2 TO TRANSACTION AGREEMENTS d303134dex9915.htm EX-99.15 29722
  Complete submission text file 0001193125-12-078249.txt   59985
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC./DE (Subject) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60409 | Film No.: 12638671
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THE INVUS GROUP, L.L.C. 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address C/O THE INVUS GROUP, L.L.C. 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 212 371 1717
Invus, L.P. (Filed by) CIK: 0001404570 (see all company filings)

IRS No.: 830359143
Type: SC 13D/A